Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Leukemia Research
|
September 10, 2015
BRAF<sup>V600E</sup> induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation
Yo-Ting Tsai, Gerard Lozanski, Amy Lehman, et al.
Cells
|
August 26, 2023
Mass Cytometry as a Tool for Investigating Senescence in Multiple Model Systems
Amina Abdul-Aziz, Raymond D Devine, Justin M Lyberger, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 27, 2019
Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells
Priscilla Do, Kyle A Beckwith, Carolyn Cheney, et al.
Blood
|
June 25, 2010
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells
Erin Hertlein, Georgia Triantafillou, Ellen J Sass, et al.
Blood
|
May 19, 2017
NF-κB p50 (<i>nfkb1</i>) contributes to pathogenesis in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia
Timothy L Chen, Minh Tran, Aparna Lakshmanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2013
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells
Sneha V Gupta, Erin Hertlein, Yanhui Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2012
Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies
Yicheng Mao, Georgia Triantafillou, Erin Hertlein, et al.
Blood
|
March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.
Journal of Hematology & Oncology
|
February 25, 2021
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL
Timothy L Chen, Bonnie Harrington, Jean Truxall, et al.
The Journal of Biological Chemistry
|
August 2, 2013
Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies
Steven E Justiniano, Saranya Elavazhagan, Kavin Fatehchand, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Leukemia Research
|
September 10, 2015
BRAF<sup>V600E</sup> induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation
Yo-Ting Tsai, Gerard Lozanski, Amy Lehman, et al.
Cells
|
August 26, 2023
Mass Cytometry as a Tool for Investigating Senescence in Multiple Model Systems
Amina Abdul-Aziz, Raymond D Devine, Justin M Lyberger, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 27, 2019
Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells
Priscilla Do, Kyle A Beckwith, Carolyn Cheney, et al.
Blood
|
June 25, 2010
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells
Erin Hertlein, Georgia Triantafillou, Ellen J Sass, et al.
Blood
|
May 19, 2017
NF-κB p50 (<i>nfkb1</i>) contributes to pathogenesis in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia
Timothy L Chen, Minh Tran, Aparna Lakshmanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2013
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells
Sneha V Gupta, Erin Hertlein, Yanhui Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2012
Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies
Yicheng Mao, Georgia Triantafillou, Erin Hertlein, et al.
Blood
|
March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.
Journal of Hematology & Oncology
|
February 25, 2021
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL
Timothy L Chen, Bonnie Harrington, Jean Truxall, et al.
The Journal of Biological Chemistry
|
August 2, 2013
Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies
Steven E Justiniano, Saranya Elavazhagan, Kavin Fatehchand, et al.
Page
of 5